It’s complicated : why do tuberculosis patients not initiate or stay adherent to treatment? a qualitative study from South Africa by Skinner, Donald & Claassens, Mareli
RESEARCH ARTICLE Open Access
It’s complicated: why do tuberculosis
patients not initiate or stay adherent to
treatment? A qualitative study from South
Africa
Donald Skinner1 and Mareli Claassens2*
Abstract
Background: Individuals who test positive for active tuberculosis (TB) but do not initiate treatment present a
challenge to TB programmes because they contribute to ongoing transmission within communities. To better
understand why individuals do not initiate treatment, or are adherent after initiating treatment, South African
respondents were approached to obtain insights as to which factors enabled and inhibited the treatment process.
Methods: This qualitative work was nested in a larger study investigating initial loss to follow-up (LTFU) amongst new
smear positive TB patients across five provinces of South Africa. In-depth interviews were done with 41 adherent and
initial LTFU respondents.
Results: Key issues contributing to initial LTFU appeared to be a poor knowledge, or low awareness of TB treatment;
stigma around TB including its connection to HIV; immediate problems in the respondents’ lives particularly poverty,
lack of access to transport and the need to continue working; and problems in the healthcare facilities including
under resourced facilities, poor functioning health systems and negative staff attitudes. In contrast the reasons
given for being adherent related to the level of illness, support received at home and healthcare facilities, a belief in
the health system and positive experiences in the health service including positive attitudes from staff.
Conclusions: Key changes need to be made to the healthcare system to enable patients to initiate treatment and
remain adherent, but the six month regimen of daily observed treatment presents real practical and personal
challenges to patients. Alternative strategies to DOTS at facility level should be investigated to bring services
closer to communities to encourage patients to access care, initiate and adhere to treatment.
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Background
South Africa is one of the focus countries of the WHO
with regards to TB, with an estimated incidence of 834/
100 000 population in 2014, the second highest globally
[1]. Even though it is a curable disease, TB is one of the
main causes of mortality in South Africa [2]. Initial loss
to follow-up (LTFU) after testing for TB, i.e. not initiating
treatment after diagnosis, is a key concern exacerbating
the TB epidemic in South Africa and internationally [3].
Studies from South Africa show an initial LTFU rate
amongst newly diagnosed smear positive patients of
between 17–25% [4, 5]. Qualitative enquiry as to why
patients do not start treatment is scarce. From a recent
systematic review investigating initial LTFU among TB
patients in National TB programmes [6], out of the
twenty-three selected for the review only one study, done
in 2005 in Malawi [7], used in-depth qualitative inter-
viewing techniques. This study found that hospital admis-
sions, delay in the receipt of sputum results and the
incorrect perception of healthcare workers that a patient
with a negative smear could not have TB, were important
reasons for initial LTFU. Subsequently few studies
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assessing initial LTFU included qualitative methods. A
study from Cambodia [8] used in-depth interviews to
ascertain enablers and inhibitors to the acceptance of
treatment initiation. They found that high indirect costs,
the anticipated/real side effects of TB treatment and the
non-acceptance of TB diagnoses were major inhibitors to
treatment initiation and therefore initial LTFU. Two
studies from India [9, 10] both used semi-structured
interviews for patients enrolled in the Revised National
Tuberculosis Control Programme and found alcoholism,
TB-related stigma, lack of TB awareness, lack of support
and the fact that patients were busy with “other jobs”
main contributors to initial LTFU. Therefore the reasons
for initial LTFU appear varied and context specific, with
extensive gaps remaining in understanding why it occurs
and what the possible enablers and inhibitors are to having
patients initiate treatment. A qualitative approach allows
for an exploration of key issues leading to initial LTFU in
relation to the context of the patients and their health ser-
vices. Our aim was therefore to understand initial LTFU in
newly diagnosed smear positive TB patients using in-depth
qualitative interviews. In addition, we explored non-
adherence to treatment. Included in this aim was the iden-
tification of enablers and inhibitors for both adherence and
initial LTFU. While the focus of the research was on initial
LTFU, the interviews produced considerable insights into
non-adherence, leading to the aim being extended to
include non-adherence.
Methods
This study was nested within a larger study (submitted)
looking at the extent of initial LTFU among TB patients.
Within the larger study, qualitative research was intro-
duced to develop an understanding of how the respon-
dents felt about the services they received and what the
personal constraints preventing them from initiating TB
treatment and staying adherent were. In-depth interviews
were done with patients who either had initiated treat-
ment and had remained adherent or initially LTFU, to
obtain insights from both groups as to which factors
enabled and inhibited the treatment process. The inter-
views were done by two fieldworkers who had experience
and training in qualitative interviewing. They were given
additional training in the research subject matter and
discussion schedule.
Setting
TB is acknowledged by the South African government to
be a major threat to the health of the South African
population. In South Africa, TB services are provided at
primary health care facilities by nurses and are free of
charge. When sputum is collected from individuals
presumed to have TB, their names are documented in a
sputum register and on starting treatment they are
entered into the TB register. In accordance with directly
observed therapy short course (DOTS), TB patients re-
ceive medication daily at their PHC clinic or from a com-
munity treatment supporter.
Population
The study was conducted at primary healthcare facilities
(PHC) in five provinces of South Africa from October
2010 - October 2011, namely the Eastern Cape, North
West, Limpopo, Mpumalanga and KwaZulu-Natal. All
have endemic TB and high HIV co-infection rates. The
facilities included urban, peri-urban and rural settings,
but none in city centres. The communities were mostly
of poor socio-economic status. Most individuals from
these communities, particularly in urban or peri-urban
settings, lived an accessible distance to a PHC but the
dispersal of communities in rural settings increased travel
requirements. Individuals were included in the study who
had a smear positive result recorded in the facility sputum
register of a PHC in the three months prior to the re-
search visit, but excluding the month just prior to the visit
to allow for treatment initiation. A person initially LTFU
was defined as documented sputum smear positive in the
sputum register, but not appearing in the TB treatment
register within four weeks since diagnosis of smear posi-
tivity at the PHC.
Sample
For this study, 41 PHC were visited. From each facility’s
sputum register we selected the first ten patients diag-
nosed but not initiated on TB treatment and ten who
had initiated treatment. Each visit to a facility lasted one
day. The first patient either on treatment or initially
LTFU was approached to have an in-depth interview.
There was no variation in age between those included
and not, but slightly more women were interviewed.
Nobody refused to be interviewed.
Interview schedule
The discussion schedule was similar for those who ad-
hered and were initially LTFU. The key question for those
who adhered was “what enabled you attending the facility
to receive your test results and to begin treatment for TB”,
and for those who were initially LTFU, “why you did not
come back to the facility to receive your test results and
potentially begin treatment for TB”. In both cases the
probes covered: accessibility of the facility, experience at
the facility, use of alternative health services, concerns
about being diagnosed with and getting treatment for TB,
difficulties generated by poverty and external events that
may have affected coming for treatment. The fieldworkers
were aware of the individuals listed as being on treatment
and initially LTFU and focused on those issues in the
interviews.
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Analysis
All the interviews were transcribed and translated into
English. Both authors read ten interviews to draw out a
set of themes which formed the basis of the analysis.
The themes drew both on the overall aims of the study
and the interview transcripts. Each theme was defined
so that a common understanding of that theme could be
referred to during the coding process. Once complete,
the authors applied this theme list to code the interviews
using Atlas ti. All interviews were read by both authors
to ensure full familiarity with the data. The first author,
male, comes from a social sciences and community based
research background, while the second author, female, is
a medical doctor with a long history in TB research. The
first author is very aware of the situation of health
services in South Africa, but had no contact with the
facilities, patients or other contextual factors in this study.
The second author who visited all the facilities and was
the principal investigator of the larger study corrected for
any contextual misunderstandings. Discussions took place
on a regular basis to clarify misunderstandings and diffe-
rences of interpretation. To validate findings interviews
were reread and new insights included. The methods used
were in accordance with well described qualitative litera-
ture [11, 12].
The analysis is divided into two sections, firstly dealing
with inhibitors leading to initial LTFU and non-adherence
and secondly enablers that facilitated initiation of treat-
ment and adherence. The text includes quotes from the
interviews to illustrate the arguments. These are linked to
the community from which the respondent came and
whether or not they were considered to be initially LTFU.
Ethics
The proposal was approved by the Health Research Ethics
Committee of Stellenbosch University. All participants
signed an informed consent form in their own language,
which was administered by the fieldworker. The letter was
at a literacy level felt to be appropriate to the respondents
and the interviewer checked that the respondents had
understood the research and the fact that the interview
would be recorded prior to them signing the letter. The
recorder was switched on for the interview only after the
consent letter was signed. The study was explained in the
respondent’s home language by a person fluent in their
language. No incentives were provided for participation.
Results
The 41 interviews were split between those adherent to
their TB treatment (22) or initially LTFU (19). The sample
was distributed across the provinces, eight respondents
from the Eastern Cape (six who were adherent: two ini-
tially LTFU), five from KwaZulu-Natal (3:2), nine from
Limpopo (4:5), fifteen from Mpumalanga (6:9) and four
from Northwest province (3:1). The results are presented
in two sections below, first describing the inhibitors to
treatment initiation and adherence and then the factors
enabling adherence.
Inhibitors leading to initial loss to follow-up (LTFU) and
non-adherence
Respondents’ reasons for not starting treatment centred
on the challenges of accessing treatment, poverty, stigma
and the difficulty of staying on treatment for an extended
period.
Not feeling ill
Respondents, who did not feel ill and were tested but
did not have any symptoms, stated that they did not be-
lieve the test results, especially when seeing TB patients
who were very ill. Many of these respondents had not
presented themselves at the facility to be tested. Facility
staff visited the households of patients already on treat-
ment to screen others residing there for undiagnosed
TB.
Yes they came with my result but I was not sure if
those were mine. …….. I thought they might have
mixed them. …………. Because I see myself that I am
still strong and big (Limpopo initial LTFU)
Even for those who initiated treatment, as they felt
better and their symptoms reduced, the motivation to
stay on treatment reduced. Respondents reflected that in
previous incidents of TB usually two months after start-
ing treatment, the motivation to stay on the medication
dropped, and treatment fatigue increased. Some reported
stopping treatment when the symptoms disappeared, but
starting again when the symptoms returned.
For about three months or four then I started feeling
those symptoms and that is when I started to take it
again (Limpopo initial LTFU)
Accessing facilities, problems of distance and transport
Where there was no community DOTS service, patients
had to make the journey daily.
… if you are not fit enough it can even take 3 hours.
…….. Too much, too much everything is a problem
there are a lot of defaulters at [] because of the
distance they are complaining because it is too far
that is why there are so many defaulters.
(North West initial LTFU)
The distribution of health facilities in urban areas were
mostly situated centrally so homes would be within a
20 min walk. Problems did occur where communities
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were dispersed, such as in rural areas, as many patients
had to travel longer distances. When the weather was bad,
particularly when raining, accessing services became
harder. In discussions with PHC staff it was reported that
mobile services have been established to facilitate access,
but as the communities got more scattered even this
service was difficult to maintain. Patients far away either
had to walk long distances or had to pay a taxi or bus fare.
Given that few TB patients are able to work these costs
made adherence difficult, especially with competing costs
such as food. When patients were really ill, the symptoms
made walking difficult with one person commenting that
the walk would take them 45 min or even three hours
leaving them feeling dizzy.
Conflict with work
Sometimes respondents were referred for treatment, but
because of work related issues, particularly work hours
and the place of work, they could not access care. Respon-
dents were concerned that if they waited for care they
would be late for work and they would lose their employ-
ment. They were also afraid to tell their employers about
their diagnosis as this could cost them their position. The
scenario created a vicious circle because the person who
was not treated would get sicker and eventually lose their
job anyway. Some who stayed on treatment lost wages for
that period. One solution was to go to the facility before
or after work, when there may be less people in the queue.
This depended on working hours, distance to work, sensi-
tivity of employers, hours when the facility operated and
the motivation of the patients.
No I did not start ………. I did not go back to them
because of my work schedule because I work from
07:00 till 16:30. There they open from 08:00 until
16:00 and on week end they are closed…
(Mpumalanga initial LTFU)
Problems experienced at the facility
A lack of organisation at the facilities causing delays in
service and queues was reported in varying degrees across
the five provinces. This principally impacted on the daily
DOTS programme, but is likely to also have affected all
other visits. Where the facilities had separate queues
or rooms for patients with TB, queues moved fast and
patients received their treatment without delays. However,
there were facilities where patients had to wait conside-
rable periods to get treatment and queues were reported
to be between 4 h to taking all day. Patients felt obliged to
get to the facility very early and wait for the facility to
open. There was a sense of despondency regarding the
slow service. Problems in the facilities often arose from
understaffing especially in relation to the size of the
population being served.
There is a queue but you must be patient to everything
because there are other people that go there. You just
need to wake up early at about 06:30 and by the time
they open up at about 07:20 you should be there.
(Eastern Cape Adherent)
Negative staff attitudes created problems in some faci-
lities, with one respondent feeling that the staff did not
care and patients just had to wait. So while the staff of
some facilities would act to make sure that those coming
for treatment got seen quickly and efficiently, in other
facilities problems were recorded. A further and more
serious inhibitor was the reporting of abusive attitudes by
staff. Complaints included that staff sent a patient away
when they assumed that he was not taking treatment,
treat patients like children and in a derogatory manner,
blame patients for problems for which they are not
responsible and for shouting and swearing at patients.
These raised anger and irritation at the services. While the
fear may motivate patients to remain on treatment, it can
make it difficult for them to return if they did not initiate
treatment. Over time it may undermine respect for the
professional status of the staff and the power of medical
authority. It is understood that many patients generate
high levels of frustration in the staff, and problems in the
levels of staffing and the lack of support for the staff also
raise staff frustrations.
I would like to continue with my treatment I just
don’t want to be shouted at because that is also
working me on my nerves I wish they can talk to this
nurse because she is making me angry sometimes.
(Eastern Cape Adherent)
This was not the universal experience and many
respondents spoke of having positive experiences at
the facilities.
There were distinct problems around the testing of
patients and particularly around informing them of their
results. Amongst the issues raised was that they were not
informed that they had TB at the facility and therefore
did not start TB treatment. Some were tested without
knowing what the test was for, so were not really aware of
needing to return for treatment. Even if the results were
positive many only found out one or two months later. In
some cases patients would return for their results on the
appointed day and the results would not be available.
At one facility the respondents reported that the staff
made TB treatment cards for patients to ensure they
knew when to return for treatment and those who
tested positive were followed-up if they were late in
returning.
At other facilities there were misunderstandings about
treatment, for example patients were not started on the
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continuation phase treatment on time as many of the
nurses were not aware of the need for this.
I went to the clinic for the test and I did it and I
brought the jars they gave me, I waited up to a
couple of days as they told me, when I came back
they told me to spit again because they lost my
results of TB. I did it again but the thing is, it took
so long to came back and I was going to lose my
patience because for me that was so serious, I wanted
to know exactly what is really the matter with me.
I looked at myself losing weight, tiredness, pains in
my body. (Mpumalanga Adherent)
Stigma
Stigma did not appear to be a major problem amongst
all the respondents but it did exist. The efforts of some
facilities to create a discrete service for TB patients, or
enabling them rapidly collecting their medication and
leaving, reduced stigma or at least limited the potential
exposure to stigma. It also decreased the possibility of
transmitting TB to other patients. However interventions
are still required in the communities to reduce stigma as
there were experiences of stigma reported. One respon-
dent said his girlfriend threw him out and his family
refused to have him in their house, so he was reduced to
steal food to survive.
You see the thing is for me to get food at this house
my niece must steal it for me because her mother
doesn’t want me. Even at the clinic they know that.
(Eastern Cape Adherent)
Respondents felt less stigmatised if someone close to
them was on TB treatment. This provided a space to
share fears and concerns. It meant that someone else
understood and supported them.
No I don’t because people don’t have a problem of TB,
but they do when it comes to HIV they are scared of
HIV. But even when I go to the clinic to collect my
ARV we do talk and also my husband is taking them
(Kwazulu Natal Adherent)
Some respondents spoke defiantly about the stigma,
expressing real anger at those who labelled them and
discriminated against them. There was resistance with
respondents stating with resolve that they would continue
despite the stigma. It appeared to be an ongoing battle in
the minds of people and it took emotional strength to
resist the stigmatising comments. The resolution of this
conflict will depend on the levels of stigma in the com-
munity, the other support systems of the patient, their de-
pendence on the community for support and the patient’s
own ego strengths. Those with more severe symptoms
said that when they were feeling very ill, stigma was not
an inhibitor. They just wanted to take their medication to
get over the illness.
I do have that problem sometimes but I told myself
that this is my life. I don’t mind what other people are
saying because TB is everywhere. People will lose
weight and gain it again it’s not going to help if I am
going stay inside the house. (Eastern Cape Adherent)
Association between TB and human immunodeficiency
virus (HIV) infection
The connection between TB and HIV presents an add-
itional challenge, as the fear and stigma attached to HIV
was seen as being transferred to TB. It does appear that
HIV carries a higher stigma than TB as HIV is not curable.
Community members are seen as looking for signs that a
person is HIV positive and increasingly TB was been seen
as indicating a dual diagnosis of HIV, stemming from the
high levels of co-infection.
Most of them are very scared to test for TB because
you know that TB is related to HIV, immediately
when you tell them that they have TB they say
“oh my god, which means I already have HIV”.
(North West Adherent)
Side effects
Respondents reported side effects such as hunger and
vomiting if they took the medication without food. It was
a particular inhibitor in poor communities and amongst
the unemployed as food was often difficult to obtain, espe-
cially when the TB patient had to give up work to be able
to collect their medication.
Also if you don’t have anything to eat and eating plays
a major role in this it boosts this medication, so if you
don’t have food this medication causes a problem in
your body. (Limpopo initial LTFU)
No other major side effects were reported as contrib-
uting to initial LTFU. In those cases where side effects
occurred, some patients’ treatments were adapted in
order to reduce side effects. The capacity to provide this
assistance depended on the service providers at the
facilities and was not easy since facilities have a standard
treatment regimen. There was a secondary cautionary
theme of distrust that the medication would not be
effective. Some commented on such cases where the
treatment did not work or where people repeatedly kept
getting TB.
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Some want to drink and smoke
The injunction not to drink and the implications of drink-
ing while on treatment made the treatment unpopular
with especially young men. Respondents reported that
alcohol tends to form a centre for social interaction in
many social circles; so not being able to drink segregates
individuals from their peer grouping. Even if they did start
taking medication, when they were feeling ill early in the
treatment process, once they are better there is a desire to
re-join their social circles.
Oh, sometimes when he was drinking we used to tell
him that he should stop drinking and to stop smoking
because they don't go together with the medication.
He eventually stopped smoking I don't know about
the drinking (Laughing). (North West Adherent)
Personal problems attributed to initial LTFU
Respondents spoke about others who did not initiate treat-
ment or who would not complete treatment, saying that
they were lazy or stupid, and as not valuing their lives. No-
body stated that they had given up on life and therefore
stopped treatment, but it was assigned to others as a reason
for not completing treatment. It is difficult to assess how
valid this is as a reason and it will require further research.
However, the levels of deprivation and hopelessness that
many people reported could contribute to such an attitude.
I think they are lazy to take them because of every
day treatment some must take it in the morning but
they will put it in the toilet and flush them or under
the bed. (Mpumalanga initial LTFU)
Enablers that facilitated initiation of treatment and
adherence
The motivations that respondents who had adhered to
treatment were largely consistent across all the regions
and reflected a need to follow the rules and a desire to
get well, especially with the twin threats of multidrug
resistant TB (MDR-TB) and HIV infection.
Following instructions
A strong desire to follow the instructions of the medical
staff was a key theme. The power of the norms of the
medical model and of the status of the health profes-
sionals carried considerable weight. Respondents stated
that since they had received the instructions they felt
obliged to follow them.
I was told that I have it [TB] and I understood that I
went there because I don’t know what is going on with
me. So if they told me that this is the problem I just
have to accept it and take my treatment that is all.
(Limpopo initial LTFU)
Feeling very ill
The level of illness and disability resulting from the symp-
toms provided a strong motivation to continue with treat-
ment. TB left many of the patients in considerable pain
and unable to complete basic personal tasks. They felt
they had no options but to adhere. Avoiding hospitalisa-
tion was a further motivation.
It was the pain I was feeling I was in pain and so that
is why I thought I should go for treatment I realized
nothing else will help me other than the treatment, I
have to take my treatment until I complete it. The
other thing is I am so scared of really sick people I
don't want a person to be so sick that they get pushed
around in wheelbarrows and things like that, so that is
why it is important for me to get help while I can still
walk on my own two feet to get help from the clinic.
(North West Adherent)
The need to be cured is the second half of the motiv-
ation. Respondents had seen the treatment work and
wanted to be healthy themselves. The direct threat of TB
meant that respondents feared death and wanted to take
treatment to stay alive to be able to care for those they
loved. Some respondents reported having stopped treat-
ment before, but now wanted to complete their treatment.
because I want to see myself better again like before
that is why I take it because I know if I don’t take
them I will die and live my children alone.
(Mpumalanga Adherent)
A strong message from those who were adherent was
the positive impact of the treatment and the return to
health of other people around. Despite some inhibitors
as expressed above, the dominant understanding was
that treatment would lead to cure. They spoke of being
able to complete chores and that their clothes now fitted
them.
Avoiding the development of MDR- or extremely drug
resistant (XDR)-TB
The increasing presence of MDR- and XDR-TB has in-
creased the motivation amongst many to seek treatment
and complete treatment, with the belief that untreated TB
becomes MDR-TB. Besides the more painful and compli-
cated treatment, a greater stigma and fear was associated
with MDR-TB.
there different kinds of TB out there like MDR and
XDR and once you have this TB and not take your
treatment you will have a problem whereby they
will tell you that the treatment is not working
properly in your (Eastern Cape Adherent)
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There was also a mistaken belief reported by one re-
spondent that untreated TB can lead to HIV, which moti-
vated those who reported this to adhere to treatment.
This is more likely to arise from the continued linking of
the two diseases.
Experiences and knowledge of other illnesses
Respondents used recovery from other illnesses as a
reason for taking treatment. Most were able to generalise
from the successes of treatment of infectious diseases and
other health problems to the likely success of TB treat-
ment. There was also an underlying message that TB is
treatable, unlike HIV, so they needed to take advantage of
the treatment and get well. This distinction was strongly
felt as most of these communities have been strongly
affected by HIV.
Being HIV positive
Respondents who were HIV positive spoke of an add-
itional motivation to be on treatment as they felt that their
life was under a more direct threat. The additional inputs
associated with being on antiretroviral treatment meant
that they understood the importance of adherence better.
They also had additional contacts with health profes-
sionals especially in the early phases of treatment.
And if they are saying its 8 month I must take
it so that I can be better again because at the
end of the day TB is curable. Yes there are
those who are not curable but if you follow
your treatment everything will be fine. Even
if its treatment for AIDS because each treatment
has its own way of working in your body.
(Limpopo Adherent)
Support
Support from family, friends and community played a
role in people being adherent. This was key on the emo-
tional level. If supported the person felt encouraged
and to have a reason to continue. At the practical level:
others assisted the patient getting to the facility to get
medication and in providing food so that they could take
the pills. Families were reported to encourage patients to
return to treatment. Conversely the absence of support
was also seen as a reason for not initiating or staying
on treatment. Support also led to respondents taking
treatment to avoid infecting those they lived with and
cared about.
I told myself that if I had TB I will accept it
and just take my treatment. Because there
are many of us here at this house if I stay
and not take my treatment I will infect others.
(Eastern Cape Adherent)
Positive relationships with the facility staff
As noted above, most respondents were positive about the
staff and their treatment at the health facilities. They felt
they could trust healthcare workers with their manage-
ment and to be confidential about their diagnosis. Where
the staff were positive and supportive, and thereby able to
develop a good relationship with the patients, this served
to encourage people to attend as the patient felt supported
and encouraged.
Discussion
This paper discusses inhibitors preventing patients from
presenting at primary healthcare facilities in South Africa
to initiate treatment and which lead to poor adherence.
Patient knowledge and beliefs are shown to be import-
ant in both presenting for treatment once diagnosed and
in adherence once on treatment, especially where the
demands of treatment conflict with lifestyle, for instance
the wish to stop treatment when feeling better, the belief
that treatment is not needed before becoming seriously ill
or the wish to stop treatment in order to return to aspects
of a previous lifestyle, particularly drinking alcohol. This is
similar to results from other sites such as Bali [13] where
it was shown that respondents did not believe the early
symptoms of TB to be serious and Timor Leste, where
respondents stopped treatment because they were feeling
better [14]. For patients who are HIV positive, adherence
on antiretroviral treatment (ART) could be improved by
addressing factors such as self-efficacy and patient beliefs
regarding the efficacy and safety of ART [15]. It therefore
seems that for both TB treatment and ART adherence,
psychological factors on the individual level is of major
importance especially in a setting like South Africa where
both diseases are of epidemic proportion and many TB
patients are co-infected with HIV. In such co-infected pa-
tients, pill burden, economic constraints, side effects, lack
of food, stigma and poor communication with healthcare
staff can be additional barriers to treatment and should
be addressed as well [16].
Although not identified in this study as a serious prob-
lem, the related area of stigma and fear around TB needs
to be monitored, as was shown previously in the Western
Cape [17] since it is getting more important as TB increas-
ingly becomes linked to HIV in the minds of community
members [18, 19]. A number of patients spoke with great
distress about being rejected by their family and commu-
nity as a result of being diagnosed with TB. This contrasts
with patients’ need for support if they are to initiate and
remain on treatment. Possible enablers to engage such
patients to initiate treatment could be peer-based support
groups, family counseling and community treatment
supporters.
Poverty leading to a lack of food or not being able to
access the healthcare facility remained a challenge to
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both initial LTFU and non-adherence in our study and
was demonstrated in previous studies from South Africa
[20] and Pakistan [21]. Severe symptoms make the situ-
ation worse as the really ill patients are unable to do much
for themselves: they have trouble walking even short dis-
tances to facilities and become reliant on others so there
is an additional need to access transport. This is similar to
what was reported from Timor Leste [14]. The impact of
having to collect medication daily from the healthcare
facility on a person’s capacity to work is having a deterrent
effect with many respondents stating that they cannot
afford to come late for work, or reveal their status to their
employers, for fear of losing the employment. The same
inhibitor was reported from China [22], Cambodia [8]
and Pakistan [21] although work place DOTS could be
effectively delivered with high adherence rates [23] and
would be a feasible solution with employer buy-in.
The healthcare facilities appeared to offer good services
and provide support for many patients. However, there
did remain many inhibitors to initiating treatment, such
as the restricted opening times noted above. This duality
was also reported from other countries, albeit not in pa-
tients initially LTFU [14, 24–26]. Some spoke highly of the
support that they received and the efforts of the staff to
give their treatment quickly and efficiently. This con-
trasted with other facilities where patients stated that they
had to wait up to four or even seven hours to be assisted,
where nurses were rude and condescending to them and
where they were fearful to go. Similar conditions were
seen in Pakistan [21].
All of these issues can be remedied, for example the
retraining of staff to improve their patient interaction
may facilitate a more welcoming environment and having
a separate queue or fast track for TB patients could be
introduced at all facilities. A concern does remain over the
provision of adequate resources to facilities, especially
staffing. This feeds into the negative staff attitudes and
makes the implementation of new ideas difficult. Alterna-
tive approaches to get treatment to patients may have to
be considered. Key to some of the problems is the directly
observed treatment, short-course (DOTS) programme
which requires patients to come to facilities daily at most
facilities. This directly impacts on patients who have
mobility problems or have to work [8, 21] and put faci-
lities under additional pressure. It is difficult to provide
communities with resources that will allow them to initi-
ate treatment or at least get to facilities. While there are
advantages to DOTS, these negative implications have to
be taken into account especially since DOTS have been
shown not to resolve poor adherence [27]. A larger com-
munity based or mobile service should be a high priority,
for instance in Cambodia where patients who were severely
ill or faced challenges regarding transport noted that home-
based care was an acceptable alternative [8], similar to
what was found in Swaziland [28] and in Uganda [29],
where TB patients indicated that community-based care
was preferred to hospital or clinic-based care. In Tanzania,
it was also shown that a patient-centred treatment
approach had better treatment success rates compared
to daily health facility DOTS [30] and that treatment
supporters who live close to the patient facilitate ad-
herence [31].
Limitations
It was not possible to implement purposive sampling as
the fieldworkers were reliant on the facility staff and the
sampling method of the larger study to access potential
interviewees. So while the sample is widely dispersed
across the country, the numbers remain small and it is
difficult to ascertain how representative they are of the
general population of TB patients. The sample size was
guided by the sampling procedure used, rather than the
process of reaching data saturation. However, there was a
consistency across the interviews, so we feel it is unlikely
that we missed major themes. We were not able to tri-
angulate findings against other data as the questions were
different in many respects from other components of the
study in which this qualitative research is nested. As the
sample was spread across five provinces of South Africa
we were unable to return to check findings. By piggyback-
ing these interviews on top of an existing national study
we were provided with an unique opportunity to draw a
sample from a large population frame.
Conclusions
Initial loss to follow-up amongst newly diagnosed smear
positive TB patients is a key concern for the programmatic
management of TB in high burden countries such as
South Africa. Healthcare staff and programme managers
should address inhibitors hindering patients to initiate
and adhere to treatment, such as patient knowledge and
beliefs, stigma and fear, and the inability to access care
due to poverty. Healthcare staff must be made aware that
their attitudes and practices influence patients’ willingness
to initiate and adhere to treatment. Alternative strategies
to DOTS at facilities must be investigated to encourage
patients to access care, initiate and adhere to treatment.
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